Petra Pharma
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
450 E 29th St Ste 506, New York City, Ne...Phone Number
(646) 440-9210Website
www.petrapharmacorp.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Petra Pharma
Petra, a clinical-stage pharmaceutical company, is a leader in phosphoinositide (PI) signaling pathway inhibition for the treatment of cancer and other serious diseases. PI signaling pathways play a central role in a variety of important cellular processes, including cell division, growth, trafficking and signaling, and impacting human health. Petra was founded in 2016 to advance the cutting-edge research of Dr. Lewis Cantley from Weill Cornell Medical Center and Dr. Nathanael Gray from Harvard Medical School and Dana-Farber Cancer Institute.Explore more
Petra Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Petra Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Petra Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Petra Pharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Petra Pharma has new funding data
Check if Petra Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Petra Pharma recently announced quarterly report
Product Launch: Get notified when Petra Pharma launches new products
Check out if Petra Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Petra Pharma
Recommended Actions
Reach out to Masked Content who joined Petra Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Petra Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Petra Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Petra Pharma.
Petra Pharma financials insights
Gather financial insights about Petra Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$48M
Petra Pharma News & Media
Petra Pharma announces licensing agreement with Takeda Pharmaceutical Company
NEW YORK, March 20, 2019 /PRNewswire/ -- Petra Pharma Corporation ("Petra"), a leader in phosphoinositide (PI) signaling pathway inhibition, announced it has secured a global license from Takeda Pharmaceutical Company Limited ("Takeda") to develop, manufacture and commercialize...Petra Pharma Presents Preclinical PIP4K2 Inhibitor Data as a Potential Treatment for Hematologic Malignancies at the 2018 American Society of Hematology Annual Meeting
NEW YORK, Dec. 1, 2018 /PRNewswire/ -- Petra Pharma Corporation, a drug development company focused on novel therapies that modulate phosphoinositide (PI) signaling pathways, today presented preclinical data in an oral presentation at the American Society of Hematology (ASH) 2018 Annual...Evotec Forms Collaboration with Petra Pharma on Indigo Platform
HAMBURG, Germany--(BUSINESS WIRE)--Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today a strategic collaboration with Petra Pharma Corporation ("Petra"). Through the collaboration, Petra will access Evotec's INDiGO platform to accelerate the development of its lead programme Petra-01, which is being developed for a range of oncological indications, through to the submission of an Investigational New Drug Application ("IND") with the U.S. Food and Drug Administr
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Petra Pharma
Sign Up For FreeTo access detailed company insights
Petra, a clinical-stage pharmaceutical company, is a leader in phosphoinositide (PI) signaling pathway inhibition for the treatment of cancer and other serious diseases. PI signaling pathways play a central role in a variety of important cellular processes, including cell division, growth, trafficking and signaling, and impacting human health. Petr... Read More
